Ikon Science
12.3.2021 14:01:43 CET | Globenewswire | Press release
SURBITON, United Kingdom, March 12, 2021 (GLOBE NEWSWIRE) -- Ikon Science, a global provider of knowledge management solutions designed to optimize subsurface discovery, is proud to expand its board of directors with the appointment of Sushma Bhan, former Chief Data Officer at Dutch Royal Shell for Subsurface and Wells, as a non-executive director.
"We are delighted to welcome Sushma to the Ikon Science board," said Denis Saussus, Chief Executive Officer, Ikon Science. "As the company celebrates 20 years of being an industry leader and launching a product that will help energy companies with their digital data transformation challenges, having Sushma’s deep strategic and technical perspective of the digital and data space will be a great benefit to our business."
"Sushma’s decision to join the Ikon Science board is a testament to the exciting journey ahead for the company and its clients," said Chris Gaffney, Managing Partner at Great Hill Partners.
Sushma is an accomplished global data leader with three decades of experience in leading enterprise data projects. At Shell, she was recognized for delivering data and digitalization strategies, building the global data community, establishing data-centricity and data quality transparency and enabling easy access solutions for asset efficiency gains in the millions. She is also an SPE International 2020 M&I award recipient, advisor for SPE Data Science and Engineering Analytics Board, co-chair of SPE’s Digital Transformation Subcommittee and an advisor on Rice University Professional Sciences Master’s Board.
About Ikon Science
Ikon Science is a global provider of knowledge management solutions to optimize subsurface discovery. For over 20 years, Ikon Science has applied deep scientific expertise and technology innovation to help customers extract more actionable knowledge from sophisticated subsurface data. By bringing digital transformation to knowledge management, Ikon helps customers make the best moves – improving accuracy, accelerating results and lowering costs. For more information, visit www.ikonscience.com.
About Great Hill Partners
Great Hill Partners is a Boston-based private equity firm targeting investments of $25 million to $500 million in high-growth companies across the software, digital commerce, financial technology, healthcare, and digital infrastructure sectors. Over the past two decades, Great Hill has raised nearly $8 billion of commitments and invested in more than 75 companies, establishing an extensive track record of building long-term partnerships with entrepreneurs and providing flexible resources to help middle-market companies’ scale. For more information, visit www.greathillpartners.com
Media Contact
Melanie Ofenloch
CMO
Ikon Science
mofenloch@ikonscience.com
To view this piece of content from ml.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Genmab A/S3.10.2026 21:40:00 CEST | Press release
Genmab Announces Rinatabart Sesutecan (Rina-S®) Phase 2 RAINFOL™-01 Results Demonstrated Durable and Clinically Meaningful Responses in Patients with Platinum-Resistant Ovarian Cancer
Chery Group3.10.2026 14:28:18 CEST | Press release
FREELANDER Marks a New Chapter at Its Global Brand Launch in Abu Dhabi
Chery Group3.10.2026 14:16:10 CEST | Press release
FREELANDER Sets Out Its International Roadmap with a Phased Expansion from the Middle East
Chery Auto3.10.2026 10:47:01 CEST | Press release
LEPAS Enters Romania: LEPAS L8 PHEV Officially Launches as First Flagship Store Opens
Novo Nordisk A/S2.10.2026 22:53:42 CEST | Press release
Novo provides update on the denecimig Biologics License Application (BLA) in the US
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
